Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

9.1%

5 terminated/withdrawn out of 55 trials

Success Rate

77.3%

-9.2% vs industry average

Late-Stage Pipeline

18%

10 trials in Phase 3/4

Results Transparency

0%

0 of 17 completed trials have results

Key Signals

15 recruiting

Enrollment Performance

Analytics

N/A
23(54.8%)
Phase 2
9(21.4%)
Phase 3
6(14.3%)
Phase 4
4(9.5%)
42Total
N/A(23)
Phase 2(9)
Phase 3(6)
Phase 4(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (55)

Showing 20 of 55 trials
NCT05310695Not ApplicableActive Not Recruiting

A Multicentre Randomised Controlled Trial of the Norwegian Health in Work Service. The NSAC Efficacy Study

Role: lead

NCT05006976Not ApplicableActive Not Recruiting

A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study

Role: lead

NCT03540420Phase 2Active Not Recruiting

Atezolizumab After Concurrent Chemo-radiotherapy Versus Chemo-radiotherapy Alone in Limited Disease Small-cell Lung Cancer

Role: collaborator

NCT06273644Not ApplicableRecruiting

Clinical Research on Acute Intermittent Porphyria and the Use of Carbohydrate-Rich Diet as a Treatment

Role: lead

NCT06599073Not ApplicableCompleted

RescueDoppler- a Disruptive Ultrasound Solution for Improved Outcome After Cardiac Arrest.

Role: collaborator

NCT06084364Phase 4Recruiting

Intraarticular Steroids, Saline and Occupational Therapy in People With CMC1 Osteoarthritis

Role: collaborator

NCT06440629Phase 4Recruiting

Effect of Proactive Therapeutic Drug Monitoring on Maintenance of Sustained Disease Control in Adults With Rheumatoid Arthritis on a Subcutaneous TNF Inhibitor: The Rheumatoid Arthritis Therapeutic DRUg Monitoring Trial (RA-DRUM)

Role: collaborator

NCT05223647Phase 3Terminated

Chemo-immunotherapy Plus Thoracic Radiotherapy in Extensive Stage Small-cell Lung Cancer

Role: collaborator

NCT07051915Phase 3Not Yet Recruiting

The Holistic Study

Role: collaborator

NCT06568276Not ApplicableRecruiting

The Benefit of Repairing the Deltoid Ligament in Unstable Ankle Fractures

Role: collaborator

NCT04574713Phase 2Completed

Candesartan for Migraine Prevention:

Role: collaborator

NCT04069897Phase 3Active Not Recruiting

Botulinum Toxin Type A Blockade of the Sphenopalatine Ganglion in Treatment-refractory Chronic Migraine

Role: collaborator

NCT05903898Not ApplicableRecruiting

Improving Stroke Care in North-Norway Through Artificial Intelligence

Role: collaborator

NCT03646357Phase 4Active Not Recruiting

BEtablocker Treatment After Acute Myocardial Infarction in Patients Without Reduced Left Ventricular Systolic Function

Role: collaborator

NCT06144905Recruiting

Norwegian Microbiota Study in Anorexia Nervosa

Role: collaborator

NCT06398314Not ApplicableRecruiting

Palliative Radiotherapy in Symptomatic Pelvic Soft Tissue Tumors

Role: collaborator

NCT06119789Phase 2Recruiting

Precision Cancer Therapy in Rare Cancers

Role: collaborator

NCT04318899Not ApplicableRecruiting

Predictors of Clinical Course and Treatment Response in DBT Programmes

Role: collaborator

NCT04513639Phase 2Recruiting

The Relapse from MRD Negativity As Indication for Treatment (REMNANT) Study

Role: collaborator

NCT05021198Recruiting

The Norwegian Cerebral Venous Thrombosis Study

Role: collaborator